# EDGAR Filing Document

**Accession Number:** 0001690947
**File Stem:** 0001157523-23-000105
**Filing Date:** 2023-1
**Character Count:** 6190
**Document Hash:** 15dc5b7ddd3c1cf2602402b544000b79
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001157523-23-000105.hdr.sgml**: 20230127

**ACCESSION NUMBER**: 0001157523-23-000105

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230127

**FILED AS OF DATE**: 20230127

**DATE AS OF CHANGE**: 20230127

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HEXO Corp.
- **CENTRAL INDEX KEY:** 0001690947
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** A8
- **FISCAL YEAR END:** 0731

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38781
- **FILM NUMBER:** 23559603

**BUSINESS ADDRESS:**
- **STREET 1:** 120 CHEMIN DE LA RIVE
- **CITY:** GATINEAU
- **STATE:** A8
- **ZIP:** J8M 1V2
- **BUSINESS PHONE:** 1-844-406-1852

**MAIL ADDRESS:**
- **STREET 1:** 120 CHEMIN DE LA RIVE
- **CITY:** GATINEAU
- **STATE:** A8
- **ZIP:** J8M 1V2

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Hydropothecary Corp
- **DATE OF NAME CHANGE:** 20161128

#### UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION <br> Washington, D.C. 20549
&nbsp;&nbsp;&nbsp;&nbsp;<br>

### FORM 6-K
&nbsp;&nbsp;&nbsp;&nbsp;<br>

#### REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE<br> SECURITIES EXCHANGE ACT OF 1934

#### For the month of January 2023<br>
&nbsp;&nbsp;&nbsp;&nbsp;<br>

Commission File Number: **001-38781**

**HEXO Corp.**<br> (Translation of registrant's name into English)<br>

**120 chemin de la Rive**<br> **Gatineau, Québec, Canada J8M 1V2**<br> (Address of principal executive office)<br>

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.<br> Form 20-F [ ] Form 40-F [ X ]<br>

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐<br>

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

------

---

| | |
|:---|:---|
| **<u>Exhibit</u>** | **<u>Description</u>** |
| [99.1](a53292139ex991.htm) | [Press release dated January 27, 2023](a53292139ex991.htm)<br>|

---

------

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
|  | **HEXO Corp.** |
| Date: January 27, 2023  | /s/ *Julius Ivancsits* |
|  | Chief Financial Officer |

---

## Exhibit 99.1

**Exhibit 99.1**<br>

# **HEXO Wins Complete Dismissal of Putative Québec Shareholder Class Action** 
GATINEAU, Québec--(BUSINESS WIRE)--January 27, 2023--HEXO Corp (TSX: HEXO; NASDAQ: HEXO) ("**HEXO**", or the "**Company**"), a leading producer of high-quality cannabis products, announced today that it has won a complete dismissal of the putative securities class action lawsuit pending before the Québec Superior Court against the Company and its former Chief Executive Officer, filed on November 19, 2019 on behalf of certain primary market and secondary market purchasers of securities of the Company.

As previously disclosed, HEXO and its former Chief Executive Officer ("**Defendants**") were named in a shareholder class action lawsuit filed in the province of Québec. The lawsuit asserted causes of action for misrepresentations and breaches of disclosure obligations under the Québec *Securities Act* and the *Civil Code of Québec* in connection with certain statements contained in HEXO's prospectus, public documents and public oral statements between April 11, 2018 and March 27, 2020.

In a 48-page opinion dated January 23, 2023, the Superior Court of Québec dismissed the Plaintiff's amended motion in its entirety, with costs. The Court agreed with the Defendants that there was "no reasonable possibility" that the secondary market claim filed under the Québec *Securities Act* had a reasonable chance of success, or that the Plaintiff had demonstrated an arguable case for a primary market class action or a civil liability class action "for misrepresentation under the general principles of fault in the civil law." The Plaintiff has a right to appeal.

"We're very satisfied with the Court's detailed opinion, which dismissed the Plaintiff's claims and supports HEXO's position," said Charlie Bowman, CEO and President of HEXO. "This favourable ruling is important for our company as we continue to build investor confidence and look to position HEXO for long-term financial success."

 **Forward Looking Statements**

This press release contains forward-looking information and forward-looking statements within the meaning of applicable securities laws ("**Forward-Looking Statements**"). Forward-Looking Statements are based on certain expectations and assumptions and are subject to known and unknown risks and uncertainties and other factors that could cause actual events, results, performance and achievements to differ materially from those anticipated in these Forward-Looking Statements. Forward-Looking Statements should not be read as guarantees of future performance or results. Readers are cautioned not to place undue reliance on these Forward-Looking Statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any Forward-Looking Statements as a result of new information or future events, or for any other reason.

 **About HEXO Corp.**

HEXO is an award-winning licensed producer of innovative products for the global cannabis market. HEXO serves the Canadian recreational market with a brand portfolio including HEXO, Redecan, UP Cannabis, Original Stash, 48North, Trail Mix, Bake Sale and Latitude brands, and the medical market in Canada. HEXO is a leading cannabis products company in Canada by recreational market share. For more information, please visit hexocorp.com.

## Contacts
 **For HEXO media or investor inquiries:** <br> Hayley Suchanek, Kaiser & Partners <br> hayley.suchanek@kaiserpartners.com <br>